291 related articles for article (PubMed ID: 33020483)
41. Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6.
Chen D; Nicholas J
J Virol; 2006 Oct; 80(19):9811-21. PubMed ID: 16973585
[TBL] [Abstract][Full Text] [Related]
42. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
Yamaguchi N; Nakayama Y; Yamaguchi N
J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
[TBL] [Abstract][Full Text] [Related]
43. A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.
Kim T; Yang SJ; Hwang D; Song J; Kim M; Kyum Kim S; Kang K; Ahn J; Lee D; Kim MY; Kim S; Seung Koo J; Seok Koh S; Kim SY; Lim DS
Nat Commun; 2015 Dec; 6():10186. PubMed ID: 26671411
[TBL] [Abstract][Full Text] [Related]
44. Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.
Li H; Nicholas J
J Virol; 2002 Jun; 76(11):5627-36. PubMed ID: 11991991
[TBL] [Abstract][Full Text] [Related]
45. Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK.
Zhao L; Hart S; Cheng J; Melenhorst JJ; Bierie B; Ernst M; Stewart C; Schaper F; Heinrich PC; Ullrich A; Robinson GW; Hennighausen L
J Biol Chem; 2004 Oct; 279(42):44093-100. PubMed ID: 15292206
[TBL] [Abstract][Full Text] [Related]
46. Investigation of mammary epithelial cell-bone marrow stroma interactions using primary human cell culture as a model of metastasis.
Brooks B; Bundred NJ; Howell A; Lang SH; Testa NG
Int J Cancer; 1997 Nov; 73(5):690-6. PubMed ID: 9398047
[TBL] [Abstract][Full Text] [Related]
47. The varying faces of IL-6: From cardiac protection to cardiac failure.
Fontes JA; Rose NR; Čiháková D
Cytokine; 2015 Jul; 74(1):62-8. PubMed ID: 25649043
[TBL] [Abstract][Full Text] [Related]
48. miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment.
Roscigno G; Cirella A; Affinito A; Quintavalle C; Scognamiglio I; Palma F; Ingenito F; Nuzzo S; De Micco F; Cuccuru A; Thomas R; Condorelli G
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230799
[TBL] [Abstract][Full Text] [Related]
49. Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
Hong BS; Ryu HS; Kim N; Kim J; Lee E; Moon H; Kim KH; Jin MS; Kwon NH; Kim S; Kim D; Chung DH; Jeong K; Kim K; Kim KY; Lee HB; Han W; Yun J; Kim JI; Noh DY; Moon HG
Cancer Res; 2019 Apr; 79(7):1520-1534. PubMed ID: 30737233
[TBL] [Abstract][Full Text] [Related]
50. Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer.
McCarthy AM; Kumar NP; He W; Regan S; Welch M; Moy B; Iafrate AJ; Chan AT; Bardia A; Armstrong K
BMC Cancer; 2020 Apr; 20(1):347. PubMed ID: 32326897
[TBL] [Abstract][Full Text] [Related]
51. Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling.
Eyre R; Alférez DG; Santiago-Gómez A; Spence K; McConnell JC; Hart C; Simões BM; Lefley D; Tulotta C; Storer J; Gurney A; Clarke N; Brown M; Howell SJ; Sims AH; Farnie G; Ottewell PD; Clarke RB
Nat Commun; 2019 Nov; 10(1):5016. PubMed ID: 31676788
[TBL] [Abstract][Full Text] [Related]
52. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
[TBL] [Abstract][Full Text] [Related]
54. Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex.
Lacroix M; Rousseau F; Guilhot F; Malinge P; Magistrelli G; Herren S; Jones SA; Jones GW; Scheller J; Lissilaa R; Kosco-Vilbois M; Johnson Z; Buatois V; Ferlin W
J Biol Chem; 2015 Nov; 290(45):26943-26953. PubMed ID: 26363066
[TBL] [Abstract][Full Text] [Related]
55. IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.
Lissat A; Joerschke M; Shinde DA; Braunschweig T; Meier A; Makowska A; Bortnick R; Henneke P; Herget G; Gorr TA; Kontny U
BMC Cancer; 2015 Jul; 15():552. PubMed ID: 26215971
[TBL] [Abstract][Full Text] [Related]
56. The force awakens: metastatic dormant cancer cells.
Park SY; Nam JS
Exp Mol Med; 2020 Apr; 52(4):569-581. PubMed ID: 32300189
[TBL] [Abstract][Full Text] [Related]
57. The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells.
Chakrabarty A; Surendran S; Bhola NE; Mishra VS; Wani TH; Baghel KS; Arteaga CL; Garg R; Chowdhury G
Carcinogenesis; 2019 Oct; 40(10):1179-1190. PubMed ID: 31219154
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
[TBL] [Abstract][Full Text] [Related]
59. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
60. Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes.
Fertig EJ; Lee E; Pandey NB; Popel AS
Sci Rep; 2015 Jul; 5():12133. PubMed ID: 26173622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
